@article{bouchard_assessing_2025,

title = {Assessing telepresence when delivering psychotherapy in videoconference: relevance and test-retest reliability of the Telepresence Videoconference Scale},

author = {S. Bouchard and C. Torres Pessanha and K. H. Tober},

url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-105023903509&partnerID=40&md5=46afce3aea732a9501fc3a1096d67673},

issn = {15548716 (ISSN)},

year  = {2025},

date = {2025-01-01},

journal = {Annual Review of CyberTherapy and Telemedicine},

volume = {23},

pages = {70–75},

abstract = {The increasing use of psychotherapy delivered via videoconference requires sound methods to assess clients' subjective experiences. Telepresence, defined as the feeling of being together in an online session despite the actual physical distance, is receiving increased attention as an important concept. The Telepresence in Videoconference Scale (TVS) assesses client telepresence during psychotherapy sessions and has been initially validated. However, its stability across sessions and its independence from the concept of treatment satisfaction need further evaluation. This paper presents an overview of studies using the TVS and examines the psychometric properties of the TVS in 65 adults (mean age = 39.9},

keywords = {adult, agoraphobia, article, Client Satisfaction Questionnaire, cognitive behavioral therapy, discriminant validity, female, generalized anxiety disorder, human, major clinical study, male, panic, Patient Satisfaction, psychological rating scale, psychotherapy, questionnaire, social interaction, Telemedicine, telepresence, Telepresence in Videoconference Scale, Telepresence Videoconference Scale, telepsychotherapy, test retest reliability, Test-retest reliability, videoconference, videoconferencing},

pubstate = {published},

tppubtype = {article}

}

@article{bouchardAssessingTelepresenceWhen2025,

title = {Assessing telepresence when delivering psychotherapy in videoconference: relevance and test-retest reliability of the Telepresence Videoconference Scale},

author = {S. Bouchard and C. Torres Pessanha and K. H. Tober},

url = {https://www.scopus.com/pages/publications/105023903509?origin=resultslist},

issn = {15548716 (ISSN)},

year  = {2025},

date = {2025-01-01},

journal = {Annual Review of CyberTherapy and Telemedicine},

volume = {23},

pages = {70–75},

publisher = {Interactive Media Institute},

abstract = {The increasing use of psychotherapy delivered via videoconference requires sound methods to assess clients' subjective experiences. Telepresence, defined as the feeling of being together in an online session despite the actual physical distance, is receiving increased attention as an important concept. The Telepresence in Videoconference Scale (TVS) assesses client telepresence during psychotherapy sessions and has been initially validated. However, its stability across sessions and its independence from the concept of treatment satisfaction need further evaluation. This paper presents an overview of studies using the TVS and examines the psychometric properties of the TVS in 65 adults (mean age = 39.9},

keywords = {adult, agoraphobia, article, Client Satisfaction Questionnaire, cognitive behavioral therapy, discriminant validity, female, generalized anxiety disorder, human, major clinical study, male, panic, Patient Satisfaction, psychological rating scale, psychotherapy, questionnaire, social interaction, Telemedicine, telepresence, Telepresence in Videoconference Scale, Telepresence Videoconference Scale, telepsychotherapy, test retest reliability, Test-retest reliability, videoconference, videoconferencing},

pubstate = {published},

tppubtype = {article}

}

@article{bouchardAssessingTelepresenceWhen2025a,

title = {Assessing telepresence when delivering psychotherapy in videoconference: relevance and test-retest reliability of the Telepresence Videoconference Scale},

author = {S. Bouchard and C. Torres Pessanha and K. H. Tober},

url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-105023903509&partnerID=40&md5=46afce3aea732a9501fc3a1096d67673},

issn = {15548716 (ISSN)},

year  = {2025},

date = {2025-01-01},

journal = {Annual Review of CyberTherapy and Telemedicine},

volume = {23},

pages = {70–75},

abstract = {The increasing use of psychotherapy delivered via videoconference requires sound methods to assess clients' subjective experiences. Telepresence, defined as the feeling of being together in an online session despite the actual physical distance, is receiving increased attention as an important concept. The Telepresence in Videoconference Scale (TVS) assesses client telepresence during psychotherapy sessions and has been initially validated. However, its stability across sessions and its independence from the concept of treatment satisfaction need further evaluation. This paper presents an overview of studies using the TVS and examines the psychometric properties of the TVS in 65 adults (mean age = 39.9},

keywords = {adult, agoraphobia, article, Client Satisfaction Questionnaire, cognitive behavioral therapy, discriminant validity, female, generalized anxiety disorder, human, major clinical study, male, panic, Patient Satisfaction, psychological rating scale, psychotherapy, questionnaire, social interaction, Telemedicine, telepresence, Telepresence in Videoconference Scale, Telepresence Videoconference Scale, telepsychotherapy, test retest reliability, Test-retest reliability, videoconference, videoconferencing},

pubstate = {published},

tppubtype = {article}

}

@article{bouchardAssessingTelepresenceWhen2025b,

title = {Assessing telepresence when delivering psychotherapy in videoconference: relevance and test-retest reliability of the Telepresence Videoconference Scale},

author = {S. Bouchard and C. Torres Pessanha and K. H. Tober},

url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-105023903509&partnerID=40&md5=46afce3aea732a9501fc3a1096d67673},

issn = {15548716 (ISSN)},

year  = {2025},

date = {2025-01-01},

journal = {Annual Review of CyberTherapy and Telemedicine},

volume = {23},

pages = {70–75},

abstract = {The increasing use of psychotherapy delivered via videoconference requires sound methods to assess clients' subjective experiences. Telepresence, defined as the feeling of being together in an online session despite the actual physical distance, is receiving increased attention as an important concept. The Telepresence in Videoconference Scale (TVS) assesses client telepresence during psychotherapy sessions and has been initially validated. However, its stability across sessions and its independence from the concept of treatment satisfaction need further evaluation. This paper presents an overview of studies using the TVS and examines the psychometric properties of the TVS in 65 adults (mean age = 39.9},

keywords = {adult, agoraphobia, article, Client Satisfaction Questionnaire, cognitive behavioral therapy, discriminant validity, female, generalized anxiety disorder, human, major clinical study, male, panic, Patient Satisfaction, psychological rating scale, psychotherapy, questionnaire, social interaction, Telemedicine, telepresence, Telepresence in Videoconference Scale, Telepresence Videoconference Scale, telepsychotherapy, test retest reliability, Test-retest reliability, videoconference, videoconferencing},

pubstate = {published},

tppubtype = {article}

}

@article{ikic_reduction_2017,

title = {Reduction in costs after treating comorbid panic disorder with agoraphobia and generalized anxiety disorder},

author = {V. Ikic and C. Bélanger and S. Bouchard and P. Gosselin and F. Langlois and J. Labrecque and M. J. Dugas and A. Marchand},

url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018690998&partnerID=40&md5=0d0600e6dd4e2a381f733ac063d639dc},

issn = {10914358},

year  = {2017},

date = {2017-01-01},

journal = {Journal of Mental Health Policy and Economics},

volume = {20},

number = {1},

pages = {11–20},

publisher = {ICMPE},

abstract = {Background: Panic disorder with agoraphobia (PDA) and generalized anxiety disorder (GAD) are impairing and costly disorders that are often misdiagnosed and left untreated despite multiple consultations. These disorders frequently co-occur, but little is known about the costs associated with their comorbidity and the impact of cognitive-behavioral therapy (CBT) on cost reduction. Aims of the Study: The first objective of this study was to assess the mental health-related costs associated with the specific concomitance of PDA and GAD. The second aim was to determine whether there is a reduction in direct and indirect mental healthrelated costs following conventional CBT for the primary disorder only (PDA or GAD) or combined CBT adapted to the comorbidity (PDA and GAD). Methods: A total of 123 participants with a double diagnosis of PDA and GAD participated in this study. Direct and indirect mental health-related costs were assessed and calculated from a societal perspective at the pre-Test, the post-Test, and the three-month, sixmonth and one-year follow-ups. Results: At the pre-Test, PDA-GAD comorbidity was found to generate a mean total cost of CAD2,000.48 (SD = 2,069.62) per participant over a three-month period. The indirect costs were much higher than the direct costs. Both treatment modalities led to significant and similar decreases in all cost categories from the pretest to the post-Test. This reduction was maintained until the oneyear follow-up. Discussion: Methodological choices may have underestimated cost evaluations. Nonetheless, this study supports the cost offset effects of both conventional CBT for primary PDA or GAD and combined CBT for PDA-GAD comorbidity. Implications for Healthcare Provision and Use: Treatment of comorbid and costly disorders with evidence-based treatments such as CBT may lead to considerable economic benefits for society. Implications for Health Policies: Considering the limited resources of healthcare systems, it is important to make choices that will lead to better accessibility of quality services. The application of CBT for PDA, GAD or both disorders and training mental health professionals in this therapeutic approach should be encouraged. Additionally, it would be favorable for insurance plans to reimburse employees for expenses associated with psychological treatment for anxiety disorders. Implications for Further Research: In addition to symptom reduction, it would be of great pertinence to explore which factors can contribute to reducing direct and indirect mental health-related costs. © 2017 ICMPE.},

note = {Publisher: ICMPE},

keywords = {adult, agoraphobia, Anxiety disorder, Anxiety Disorders, article, cognitive behavioral therapy, cognitive therapy, comorbidity, controlled study, dysthymia, economics, female, follow up, generalized anxiety disorder, health care cost, Health Care Costs, human, Humans, major clinical study, major depression, male, Mental health, obsessive compulsive disorder, panic, Panic Disorder, phobia, posttraumatic stress disorder, procedures, Quebec, social phobia, statistics and numerical data},

pubstate = {published},

tppubtype = {article}

}

@article{ikicReductionCostsTreating2017,

title = {Reduction in costs after treating comorbid panic disorder with agoraphobia and generalized anxiety disorder},

author = {V. Ikic and C. Bélanger and S. Bouchard and P. Gosselin and F. Langlois and J. Labrecque and M. J. Dugas and A. Marchand},

url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018690998&partnerID=40&md5=0d0600e6dd4e2a381f733ac063d639dc},

issn = {10914358},

year  = {2017},

date = {2017-01-01},

journal = {Journal of Mental Health Policy and Economics},

volume = {20},

number = {1},

pages = {11–20},

publisher = {ICMPE},

abstract = {Background: Panic disorder with agoraphobia (PDA) and generalized anxiety disorder (GAD) are impairing and costly disorders that are often misdiagnosed and left untreated despite multiple consultations. These disorders frequently co-occur, but little is known about the costs associated with their comorbidity and the impact of cognitive-behavioral therapy (CBT) on cost reduction. Aims of the Study: The first objective of this study was to assess the mental health-related costs associated with the specific concomitance of PDA and GAD. The second aim was to determine whether there is a reduction in direct and indirect mental healthrelated costs following conventional CBT for the primary disorder only (PDA or GAD) or combined CBT adapted to the comorbidity (PDA and GAD). Methods: A total of 123 participants with a double diagnosis of PDA and GAD participated in this study. Direct and indirect mental health-related costs were assessed and calculated from a societal perspective at the pre-Test, the post-Test, and the three-month, sixmonth and one-year follow-ups. Results: At the pre-Test, PDA-GAD comorbidity was found to generate a mean total cost of CAD2,000.48 (SD = 2,069.62) per participant over a three-month period. The indirect costs were much higher than the direct costs. Both treatment modalities led to significant and similar decreases in all cost categories from the pretest to the post-Test. This reduction was maintained until the oneyear follow-up. Discussion: Methodological choices may have underestimated cost evaluations. Nonetheless, this study supports the cost offset effects of both conventional CBT for primary PDA or GAD and combined CBT for PDA-GAD comorbidity. Implications for Healthcare Provision and Use: Treatment of comorbid and costly disorders with evidence-based treatments such as CBT may lead to considerable economic benefits for society. Implications for Health Policies: Considering the limited resources of healthcare systems, it is important to make choices that will lead to better accessibility of quality services. The application of CBT for PDA, GAD or both disorders and training mental health professionals in this therapeutic approach should be encouraged. Additionally, it would be favorable for insurance plans to reimburse employees for expenses associated with psychological treatment for anxiety disorders. Implications for Further Research: In addition to symptom reduction, it would be of great pertinence to explore which factors can contribute to reducing direct and indirect mental health-related costs. © 2017 ICMPE.},

keywords = {adult, agoraphobia, Anxiety disorder, Anxiety Disorders, article, cognitive behavioral therapy, cognitive therapy, comorbidity, controlled study, dysthymia, economics, female, follow up, generalized anxiety disorder, health care cost, Health Care Costs, human, Humans, major clinical study, major depression, male, Mental health, obsessive compulsive disorder, panic, Panic Disorder, phobia, posttraumatic stress disorder, procedures, Quebec, social phobia, statistics and numerical data},

pubstate = {published},

tppubtype = {article}

}

@article{cousineau_insomnia_2016,

title = {Insomnia symptoms following treatment for comorbid panic disorder with agoraphobia and generalized anxiety disorder},

author = {H. Cousineau and A. Marchand and S. Bouchard and C. Bélanger and P. Gosselin and F. Langlois and J. Labrecque and M. J. Dugas and G. Belleville},

url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-84962128029&doi=10.1097%2fNMD.0000000000000466&partnerID=40&md5=2ca2dd82c29553bd7377ba64dd5522cc},

doi = {10.1097/NMD.0000000000000466},

issn = {00223018},

year  = {2016},

date = {2016-01-01},

journal = {Journal of Nervous and Mental Disease},

volume = {204},

number = {4},

pages = {267–273},

publisher = {Lippincott Williams and Wilkins},

abstract = {Patients with panic disorder with agoraphobia (PDA) or generalized anxiety disorder (GAD) frequently also suffer from insomnia. However, the impact of cognitive-behavioral therapy (CBT) for anxiety disorders on insomnia has been understudied. Furthermore, comorbidity between anxiety disorders is common. Our main objective was to assess the impact of CBT for PDA or GAD on insomnia. In a quasi-experimental design, 86 participants with PDA and GAD received conventional CBT for their primary disorder or combined CBT for both disorders. Overall, CBTs had a significant impact on reducing insomnia symptoms (η2 = 0.58). However, among people with insomnia at pretest (67%), 33% still had an insomnia diagnosis, and the majority (63%) had clinically significant residual insomnia following treatment. In conclusion, the CBTs had a positive effect on the reduction of insomnia, but a significant proportion of participants still had insomnia problems following treatment. Clinicians should address insomnia during CBT for PDA and GAD. Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.},

note = {Publisher: Lippincott Williams and Wilkins},

keywords = {adult, agoraphobia, antidepressant agent, Anxiety Disorders, anxiolytic agent, article, clinical trial, cognitive therapy, cohort analysis, Cohort Studies, Combined Modality Therapy, comorbidity, comparative study, controlled study, Depression, disease severity, female, generalized anxiety disorder, human, Humans, hypnotic agent, insomnia, major clinical study, male, Middle Aged, multicenter study, multimodality cancer therapy, nocturnal panic attack, panic, Panic Disorder, panic disorder with agoraphobia, patient worry, procedures, psychoeducation, psychology, psychotropic agent, Psychotropic Drugs, quasi experimental study, Quebec, randomized controlled trial, Sleep Initiation and Maintenance Disorders, statistical significance, treatment outcome, wakefulness, Young Adult},

pubstate = {published},

tppubtype = {article}

}

@article{cousineauInsomniaSymptomsFollowing2016,

title = {Insomnia symptoms following treatment for comorbid panic disorder with agoraphobia and generalized anxiety disorder},

author = {H. Cousineau and A. Marchand and S. Bouchard and C. Bélanger and P. Gosselin and F. Langlois and J. Labrecque and M. J. Dugas and G. Belleville},

url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-84962128029&doi=10.1097%2fNMD.0000000000000466&partnerID=40&md5=2ca2dd82c29553bd7377ba64dd5522cc},

doi = {10.1097/NMD.0000000000000466},

issn = {00223018},

year  = {2016},

date = {2016-01-01},

journal = {Journal of Nervous and Mental Disease},

volume = {204},

number = {4},

pages = {267–273},

publisher = {Lippincott Williams and Wilkins},

abstract = {Patients with panic disorder with agoraphobia (PDA) or generalized anxiety disorder (GAD) frequently also suffer from insomnia. However, the impact of cognitive-behavioral therapy (CBT) for anxiety disorders on insomnia has been understudied. Furthermore, comorbidity between anxiety disorders is common. Our main objective was to assess the impact of CBT for PDA or GAD on insomnia. In a quasi-experimental design, 86 participants with PDA and GAD received conventional CBT for their primary disorder or combined CBT for both disorders. Overall, CBTs had a significant impact on reducing insomnia symptoms (η2 = 0.58). However, among people with insomnia at pretest (67%), 33% still had an insomnia diagnosis, and the majority (63%) had clinically significant residual insomnia following treatment. In conclusion, the CBTs had a positive effect on the reduction of insomnia, but a significant proportion of participants still had insomnia problems following treatment. Clinicians should address insomnia during CBT for PDA and GAD. Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.},

keywords = {adult, agoraphobia, antidepressant agent, Anxiety Disorders, anxiolytic agent, article, clinical trial, cognitive therapy, cohort analysis, Cohort Studies, Combined Modality Therapy, comorbidity, comparative study, controlled study, Depression, disease severity, female, generalized anxiety disorder, human, Humans, hypnotic agent, insomnia, major clinical study, male, Middle Aged, multicenter study, multimodality cancer therapy, nocturnal panic attack, panic, Panic Disorder, panic disorder with agoraphobia, patient worry, procedures, psychoeducation, psychology, psychotropic agent, Psychotropic Drugs, quasi experimental study, Quebec, randomized controlled trial, Sleep Initiation and Maintenance Disorders, statistical significance, treatment outcome, wakefulness, Young Adult},

pubstate = {published},

tppubtype = {article}

}

@article{grenier_using_2015,

title = {Using virtual reality to improve the efficacy of cognitive-behavioral therapy (CBT) in the treatment of late-life anxiety: Preliminary recommendations for future research},

author = {S. Grenier and H. Forget and S. Bouchard and S. Isere and S. Belleville and O. Potvin and M. -È. Rioux and M. Talbot and N. A. Pachana and R. C. Oude Voshaar},

url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-84931830085&doi=10.1017%2fS1041610214002300&partnerID=40&md5=6a937a7a7f13fca31c84fc7859b365d0},

doi = {10.1017/S1041610214002300},

issn = {10416102},

year  = {2015},

date = {2015-01-01},

journal = {International Psychogeriatrics},

volume = {27},

number = {7},

pages = {1217–1225},

publisher = {Cambridge University Press},

abstract = {Cognitive-behavioral therapy (CBT) using traditional exposure techniques (i.e. imaginal and in vivo) seems less effective to treat anxiety in older adults than in younger ones. This is particularly true when imaginal exposure is used to confront the older patient to inaccessible (e.g. fear of flying) or less tangible/controllable anxiety triggers (e.g. fear of illness). Indeed, imaginal exposure may become less effective as the person gets older since normal aging is characterized by the decline in cognitive functions involved in the creation of vivid/detailed mental images. One way to circumvent this difficulty is to expose the older patient to a virtual environment that does not require the ability to imagine the frightening situation. In virtuo exposure has proven to be efficient to treat anxiety in working-age people. In virtuo exposure could be employed to improve the efficacy of CBT with exposure sessions in the treatment of late-life anxiety? The current paper explores this question and suggests new research avenues. Copyright © International Psychogeriatric Association 2014.},

note = {Publisher: Cambridge University Press},

keywords = {adult, aged, aging, Anxiety, Anxiety disorder, Anxiety Disorders, clinical effectiveness, cognition, cognitive defect, cognitive therapy, Depression, disease association, exposure, Fear, generalized anxiety disorder, gerontopsychiatry, human, Humans, late life anxiety disorder, panic, patient counseling, posttraumatic stress disorder, procedures, psychology, randomized controlled trial (topic), relaxation training, Research, review, Social Support, treatment outcome, trends, virtual reality, virtual reality exposure therapy},

pubstate = {published},

tppubtype = {article}

}

@article{grenierUsingVirtualReality2015,

title = {Using virtual reality to improve the efficacy of cognitive-behavioral therapy (CBT) in the treatment of late-life anxiety: Preliminary recommendations for future research},

author = {S. Grenier and H. Forget and S. Bouchard and S. Isere and S. Belleville and O. Potvin and M. -È. Rioux and M. Talbot and N. A. Pachana and R. C. Oude Voshaar},

url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-84931830085&doi=10.1017%2fS1041610214002300&partnerID=40&md5=6a937a7a7f13fca31c84fc7859b365d0},

doi = {10.1017/S1041610214002300},

issn = {10416102},

year  = {2015},

date = {2015-01-01},

journal = {International Psychogeriatrics},

volume = {27},

number = {7},

pages = {1217–1225},

publisher = {Cambridge University Press},

abstract = {Cognitive-behavioral therapy (CBT) using traditional exposure techniques (i.e. imaginal and in vivo) seems less effective to treat anxiety in older adults than in younger ones. This is particularly true when imaginal exposure is used to confront the older patient to inaccessible (e.g. fear of flying) or less tangible/controllable anxiety triggers (e.g. fear of illness). Indeed, imaginal exposure may become less effective as the person gets older since normal aging is characterized by the decline in cognitive functions involved in the creation of vivid/detailed mental images. One way to circumvent this difficulty is to expose the older patient to a virtual environment that does not require the ability to imagine the frightening situation. In virtuo exposure has proven to be efficient to treat anxiety in working-age people. In virtuo exposure could be employed to improve the efficacy of CBT with exposure sessions in the treatment of late-life anxiety? The current paper explores this question and suggests new research avenues. Copyright © International Psychogeriatric Association 2014.},

keywords = {adult, aged, aging, Anxiety, Anxiety disorder, Anxiety Disorders, clinical effectiveness, cognition, cognitive defect, cognitive therapy, Depression, disease association, exposure, Fear, generalized anxiety disorder, gerontopsychiatry, human, Humans, late life anxiety disorder, panic, patient counseling, posttraumatic stress disorder, procedures, psychology, randomized controlled trial (topic), relaxation training, Research, review, Social Support, treatment outcome, trends, virtual reality, virtual reality exposure therapy},

pubstate = {published},

tppubtype = {article}

}